Rocket


News + Filings
Transactions



Lavelle Erin

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/08/2023Neoleukin Therapeutics, Inc.AQXPGrantStock Option (Right to Buy)25k$0.79$19.8k 06/08/2023
10/31/2022Eliem Therapeutics, Inc.ELYMGrantStock Option (Right to Buy)170k$3.27$555.9k 10/31/2022
05/12/2022Neoleukin Therapeutics, Inc.AQXPGrantStock Option (Right to Buy)25k$1.07$26.8k 05/12/2022
01/27/2022Eliem Therapeutics, Inc.ELYMGrantStock Option (Right to Buy)170k$8.21$1.4M 01/27/2022
10/22/2019ALDER BIOPHARMACEUTICALS INCALDRDispositionStock Option (Right to Buy)150k$14.00$2.1M 10/22/2019
10/22/2019ALDER BIOPHARMACEUTICALS INCALDROtherCommon Stock16.1k$18.00$289.7k 10/22/2019
10/22/2019ALDER BIOPHARMACEUTICALS INCALDRDispositionStock Option (Right to Buy)300k$14.55$4.4M 10/22/2019
10/22/2019ALDER BIOPHARMACEUTICALS INCALDRGrantCommon Stock11.7k$0.00$0 10/22/2019
04/25/2019ALDER BIOPHARMACEUTICALS INCALDRSaleCommon Stock1.4k$13.67$19.6k 04/23/2019
04/23/2019ALDER BIOPHARMACEUTICALS INCALDRGrant 5.8k$0.00$0 04/23/2019
02/06/2019ALDER BIOPHARMACEUTICALS INCALDRGrantStock Option (Right to Buy)150k$14.00$2.1M 02/06/2019
04/16/2018ALDER BIOPHARMACEUTICALS INCALDRGrantStock Option (Right to Buy)300k$14.55$4.4M 04/16/2018

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy